Walleye Capital
ASMB icon

Walleye Capital’s Assembly Biosciences ASMB Stock Holding History

Walleye Capital’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-24,501
Closed -$627K – 4545
2025
Q3 		$627K Buy
+24,501
New +$538K ﹤0.01% 2441
2022
Q1 		– Sell
-6,281
Closed -$176K – 2275
2021
Q4 		$176K Buy
6,281
+350
+6% +$11.5K 0.01% 1514
2021
Q3 		$248 Buy
+5,931
New +$249K 0.01% 1112
2021
Q2 		– Sell
-6,710
Closed -$370 – 1337
2021
Q1 		$370 Sell
6,710
-1,687
-20% -$112K 0.02% 694
2020
Q4 		$610 Buy
+8,397
New +$985K 0.04% 418

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Walleye Capital's ASMB Position: Q4 2025 in Review

Walleye Capital sold out of Assembly Biosciences (ASMB) in Q4 2025, closing a stake of 24,501 shares — an estimated $627K sold.

Walleye Capital first reported a position in ASMB in Q4 2020 and held it in 5 quarters. The position peaked at $627K in Q3 2025. 69 funds tracked by Wall St. Rank hold ASMB as of Q4 2025.

  • Walleye Capital reported no remaining Assembly Biosciences position as of Q4 2025 after selling out during the quarter.
  • Walleye Capital sold 24,501 Assembly Biosciences shares in Q4 2025, an estimated $627K.
  • Walleye Capital first reported a position in Assembly Biosciences in Q4 2020 and held it in 5 quarters.
  • Walleye Capital's Assembly Biosciences position peaked at $627K in Q3 2025.
  • 69 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.